1,549
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Plasma metabolic profiling of normal and dysmenorrhea syndrome rats and the effects of Xiang–Fu–Si–Wu Decoction intervention

, , , , , & show all
Pages 603-613 | Received 08 Oct 2013, Accepted 17 Oct 2013, Published online: 21 Nov 2013

References

  • Akerlund M. (2002). Involvement of oxytocin and vasopressin in the pathophysiology of preterm labor and primary dysmenorrhea. Prog Brain Res 139:359–65
  • Bell-Parikh LC, Ide T, Lawson JA, et al. (2003). Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. J Clin Invest 112:945–55
  • Cheng XM, Zhao T, Yang T, et al. (2010). HPLC fingerprints combined with principal component analysis, hierarchical cluster analysis and linear discriminant analysis for the classification and differentiation of Peganum sp. indigenous to China. Phytochem Anal 21:279–89
  • Churchwell MI, Twaddle NC, Meeker LR, Doerge DR. (2005). Improving LC-MS sensitivity through increases in chromatographic performance: Comparisons of UPLC-ES/MS/MS to HPLC-ES/MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 825:134–43
  • Couchman L, Morgan PE. (2011). LC-MS in analytical toxicology: Some practical considerations. Biomed Chromatogr 25:100–23
  • Dawood MY. (2006). Primary dysmenorrhea: Advances in pathogenesis and management. Obstet Gynecol 108:428–41
  • Dong J, Cai XM, Zhao LL, et al. (2010). Lysophosphatidylcholine profiling of plasma: Discrimination of isomers and discovery of lung cancer biomarkers. Metabolomics 6:478–88
  • Doubova SV, Morales HR, Hernandez SF, et al. (2007). Effect of a Psidii guajavae folium extract in the treatment of primary dysmenorrhea: A randomized clinical trial. J Ethnopharmacol 110:305–10
  • Hsu CS, Yang JK, Yang LL. (2006). Effect of “Dang-Qui-Shao-Yao-San” a Chinese medicinal prescription for dysmenorrhea on uterus contractility in vitro. Phytomedicine 13:94–100
  • Idborg H, Zamani L, Edlund PO, et al. (2005). Metabolic fingerprinting of rat urine by LC/MS Part 2. Data pretreatment methods for handling of complex data. J Chromatogr B Analyt Technol Biomed Life Sci 828:14--20
  • Jabbour HN, Sales KJ, Catalano RD, Norman JE. (2009). Inflammatory pathways in female reproductive health and disease. Reproduction 138:903–19
  • Jia LW, Chen J, Yin PY, et al. (2008). Serum metabonomics study of chronic renal failure by ultra performance liquid chromatography coupled with Q-TOF mass spectrometry. Metabolomics 4:183--9
  • Kabarowski JH. (2009). G2A and LPC: Regulatory functions in immunity. Prostaglandins Other Lipid Mediat 89:73–81
  • Koike H, Egawa H, Ohtsuka T, et al. (1992). Correlation between dysmenorrheic severity and prostaglandin production in women with endometriosis. Prostaglandins Leukot Essent Fatty Acids 46:133–7
  • Li Y, Liu S, Wang C, et al. (2010). Novel biomarkers of 3-chloro-1,2-propanediol exposure by ultra performance liquid chromatography/mass spectrometry based metabonomic analysis of rat urine. Chem Res Toxicol 23:1012–17
  • Liebisch G, Drobnik W, Lieser B, et al. (2002). High-throughput quantification of lysophosphatidylcholine by electrospray ionization tandem mass spectrometry. Clin Chem 48:2217--24
  • Liu P, Duan JA, Hua YQ, et al. (2011). Effects of Xiang–Fu–Si–Wu decoction and its main components for dysmenorrhea on uterus contraction. J Ethnopharmacol 133:591–7
  • Liu P, Duan JA, Wang PJ, et al. (2013). Biomarkers of primary dysmenorrhea and herbal formula intervention: An exploratory metabonomics study of blood plasma and urine. Mol BioSyst 9:77–87
  • Martinez-Gras I, Perez-Nievas BG, Garcia-Bueno B, et al. (2011). The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia. Schizophr Res 128:15–22
  • Mensch J, Noppe M, Adriaensen J, et al. (2007). Novel generic UPLC/MS/MS method for high throughput analysis applied to permeability assessment in early drug discovery. J Chromatogr B Analyt Technol Biomed Life Sci 847:182–7
  • Murphy RC, Barkley RM, Zemski Berry K, et al. (2005). Electrospray ionization and tandem mass spectrometry of eicosanoids. Anal Biochem 346:1–42
  • National Research Council (US). Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Institute for Laboratory Animal Research (U.S.), National Academies Press (U.S.). (2011). Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academies Press, 4--8
  • Nigam S, Benedetto C, Zonca M, et al. (1991). Increased concentrations of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhea. Eicosanoids 4:137–41
  • Plumb RS, Stumpf CL, Granger JH, et al. (2003). Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids. Rapid Commun Mass Spectrom 17:2632–8
  • Powell WS. (2003). 15-Deoxy-delta12,14-PGJ2: Endogenous PPARgamma ligand or minor eicosanoid degradation product? J Clin Invest 112:828–30.
  • Schmauss C, Yaksh TL. (1984). In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. J Pharmacol Exp Ther 228:1–12
  • Srinivas NR. (2006). Applicability of bioanalysis of multiple analytes in drug discovery and development: Review of select case studies including assay development considerations. Biomed Chromatogr 20:383–414
  • Tao X, Liu Y, Wang Y, et al. (2008). GC-MS with ethyl chloroformate derivatization for comprehensive analysis of metabolites in serum and its application to human uremia. Anal Bioanal Chem 391:2881–9
  • Tong X, Sun H, Yan GL, et al. (2011). Evaluation study on urine metabolomics in yinhuang rat model induced by triplet factors of rhubarb, ethanol, and alpha-nephthylisothiolyanate. Chinese J Integrative Med 17:369–75
  • Wilson ID, Nicholson JK, Castro-Perez J, et al. (2005). High resolution “Ultra performance” liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J Proteome Res 4:591–8
  • Yan JJ, Jung JS, Lee JE, et al. (2004). Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat Med 10:161–7
  • Zhang J, Yan L, Chen W, et al. (2009). Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system. Anal Chim Acta 650:16–22
  • Zhao X, Zhang Y, Meng X, et al. (2008). Effect of a traditional Chinese medicine preparation Xindi soft capsule on rat model of acute blood stasis: a urinary metabonomics study based on liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 873:151--8
  • Zhu K, Baudhuin LM, Hong G, et al. (2001). Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J Biol Chem 276:41325–35

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.